Barclays raised the firm’s price target on Bausch + Lomb (BLCO) to $19 from $18 and keeps an Equal Weight rating on the shares. The firm says ...

The global vision care products market is projected to reach USD 103.7 billion by 2032, growing at a CAGR of 6.21%. This growth ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...

Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the treatment once they stop wearing the lenses, new research shows.

Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit ...

The key players in the global ophthalmic lasers market include Alcon, Bausch + Lomb, Johnson & Johnson, NIDEK, and ZEISS. Furthermore, Alcon, a prominent player in the global healthcare sector ...

VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX ... Although there is currently no cure for glaucoma, early intervention – including prescription eye drops – can help slow the disease’s ...

Michael Bromberg is a finance editor with a decade of experience. He is an expert at elucidating complex financial topics in clear, concise language. Michael received a Bachelor of Arts in ...

Evercore ISI lowered the firm’s price target on Bausch + Lomb (BLCO) to $22 from $25 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science ...

Wetherspoons is making a huge change across its 750 pubs around the country that will no doubt delight their thousands of customers. The offer will start from January 2 and go right up until ...